Recombinant Human MYT1 Protein (His903-Val1121), N-His tagged
Cat.No. : | MYT1-4657H |
Product Overview : | Recombinant human MYT1 (His903-Val1121) fused with the N-His tag was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Source : | E. coli |
Species : | Human |
Tag : | N-His |
Form : | Lyophilized powder/frozen liquid |
Molecular Mass : | 26.40 kDa |
Protein Length : | His903-Val1121 |
Purity : | >90% as determined by SDS-PAGE. |
Notes : | For research use only. |
Storage : | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 centigrade for one week. Store at -20 to -80 centigrade for twelve months from the date of receipt. |
Storage Buffer : | 0.01M PBS, pH 7.4, 0.02% NLS |
Reconstitution : | Reconstitute in sterile water for a stock solution. |
Shipping : | They are shipped out with dry ice/blue ice unless customers require otherwise. |
Gene Name : | MYT1 myelin transcription factor 1 [ Homo sapiens (human) ] |
Official Symbol : | MYT1 |
Synonyms : | MYT1; myelin transcription factor 1; PLPB1; MTF1; MYTI; myelin transcription factor I; proteolipid protein binding protein; proteolipid protein-binding protein; C20orf36; |
Gene ID : | 4661 |
mRNA Refseq : | NM_004535 |
Protein Refseq : | NP_004526 |
MIM : | 600379 |
UniProt ID : | Q01538 |
Products Types
◆ Recombinant Protein | ||
MYT1-17H | Recombinant Active Human MYT1 Protein (Full length), N-His-tagged | +Inquiry |
MYT1-5868H | Recombinant Human MYT1 Protein, GST-tagged | +Inquiry |
MYT1-1288H | Recombinant Human MYT1 Protein (900-1101 aa), His-tagged | +Inquiry |
MYT1-3004H | Recombinant Human MYT1 Protein, GST-tagged | +Inquiry |
MYT1-1156H | Recombinant Human MYT1, His-tagged | +Inquiry |
◆ Lysates | ||
MYT1-1163HCL | Recombinant Human MYT1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionStudies have shown that MYT1 recombinant protein may be involved in the occurrence and progression of tumors, especially in neurological tumors and breast cancer.
The current treatments for MYT1 recombinant protein mainly include gene therapy, protein replacement therapy, and drug therapy for cell cycle and DNA repair processes.
The level of MYT1 recombinant protein can be detected by gene sequencing and protein detection methods.
MYT1 recombinant protein is associated with some tumors, neurological diseases, and autoimmune diseases.
If the level of MYT1 recombinant protein is abnormal, the treatment may include the use of drugs or other special treatments, depending on the condition and the doctor's recommendation.
Studies have shown that MYT1 recombinant protein may be associated with cardiovascular disease, liver disease, and lung disease.
Customer Reviews (3)
Write a reviewMYT1 is highly expressed, which can effectively synthesize a large number of target proteins in host cells.
MYT1 is highly pure and not adulterated with other proteins or impurities.
Laboratory personnel reported that the protein was easy to handle, able to meet the needs of experiments, and had a good price-performance ratio.
Ask a Question for All MYT1 Products
Required fields are marked with *
My Review for All MYT1 Products
Required fields are marked with *
Inquiry Basket